You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨銀河證券:華熙生物長期成長性良好,維持“推薦”評級

銀河證券日前指出,華熙生物作爲全球規模最大的透明質酸供應商,公司以透明質酸爲基石,構建了從原料到產品的全產業鏈體系,並通過創新技術轉化將產品邊界拓展至透明質酸衍生物、麥角硫因、Y-氨基丁酸等多元生物活性物,未來有望充分受益國內消費升級下生命健康產品需求增長。同時依託合成生物領域的產業轉化優勢,公司前瞻性佈局糖生物學和細胞生物學兩大生命科技新方向,開啓第三次戰略升級。我們認爲公司前期對於各項業務的戰略變革效果預計將逐漸顯現、有望於近期迎來經營拐點,核心業務經營有望企穩回升。公司是全球領先的生物活性材料科技企業,深耕合成生物學技術開拓全產業鏈佈局,品牌矩陣豐富,長期成長性良好。維持“推薦”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account